The diabetic brain and cognition

The prevalence of both Alzheimer’s disease (AD) and vascular dementia (VaD) is increasing with the aging of the population. Studies from the last several years have shown that people with diabetes have an increased risk for dementia and cognitive impairment. Therefore, the authors of this consensus...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Riederer Peter
Korczyn Amos D.
Ali Sameh S.
Bajenaru Ovidiu
Choi Mun Seong
Chopp Michael
Dermanovic-Dobrota Vesna
Grünblatt Edna
Jellinger Kurt A.
Kamal Mohammad Amjad
Kamal Warda
Vécsei László
Wojszel Zyta Beata
Yaman Hakan
Zhang Zheng G.
Dokumentumtípus: Cikk
Megjelent: Springer-Verlag 2017
Sorozat:JOURNAL OF NEURAL TRANSMISSION 124 No. 11
doi:10.1007/s00702-017-1763-2

mtmt:3254480
Online Access:http://publicatio.bibl.u-szeged.hu/12307
Leíró adatok
Tartalmi kivonat:The prevalence of both Alzheimer’s disease (AD) and vascular dementia (VaD) is increasing with the aging of the population. Studies from the last several years have shown that people with diabetes have an increased risk for dementia and cognitive impairment. Therefore, the authors of this consensus review tried to elaborate on the role of diabetes, especially diabetes type 2 (T2DM) in both AD and VaD. Based on the clinical and experimental work of scientists from 18 countries participating in the International Congress on Vascular Disorders and on literature search using PUBMED, it can be concluded that T2DM is a risk factor for both, AD and VaD, based on a pathology of glucose utilization. This pathology is the consequence of a disturbance of insulin-related mechanisms leading to brain insulin resistance. Although the underlying pathological mechanisms for AD and VaD are different in many aspects, the contribution of T2DM and insulin resistant brain state (IRBS) to cerebrovascular disturbances in both disorders cannot be neglected. Therefore, early diagnosis of metabolic parameters including those relevant for T2DM is required. Moreover, it is possible that therapeutic options utilized today for diabetes treatment may also have an effect on the risk for dementia. T2DM/IRBS contribute to pathological processes in AD and VaD. © 2017 Springer-Verlag GmbH Austria
Terjedelem/Fizikai jellemzők:1431-1454
ISSN:0300-9564